Search Results
Jan 06, 2026, 09:00 ET Elitewheels & evolve Power UCI Pro Team Solution Tech - NIPPO - Rali Toward a Potential Grand Tour Breakthrough in 2026
evolve brings its high-performance CIMA frameset to the partnership for 2026. Built with TORAY T1100, T800, and M40 carbon, the unpainted M-size frame weighs just 650g, balancing ultra-lightweight construction with race-level stiffness. Wind
More news about: Elitewheels
Jan 06, 2026, 09:00 ET NFL Rookie Tetairoa McMillan, MLB All-Star Devin Williams, and NBA Veteran Jerami Grant Invest in Waiākea Hawaiian Volcanic Water -- Joining Aaron Judge, Myles Garrett, Klay Thompson, and others
Jan. 6, 2026 /PRNewswire/ -- Waiākea Hawaiian Volcanic Beverages is excited to welcome Tetairoa McMillan (T-Mac), NFL rising rookie sensation for the Carolina Panthers; Devin Williams, recently signed MLB pitcher for the New York Mets; and Jerami Grant,
More news about: Waiākea Hawaiian Volcanic Beverages
Jan 06, 2026, 09:00 ET TCL Advances Next-Gen Connectivity with 5G Wi-Fi 7 Mobile Wi-Fi and Wi-Fi 7 Mesh Router to Power Modern Connected Lifestyles
to 3.6Gbps dual-band Wi-Fi 7, delivering high-speed connectivity for all your needs. To ensure these speeds reach further, it utilizes a specialized 3T3R (2ss) configuration at 5GHz for extended coverage, maintaining strong signals over longer distances. This robust foundation supports massive Wi-Fi connections
More news about: TCL
Jan 06, 2026, 08:28 ET CooperVision lanzará las lentes de contacto blandas MyDay® MiSight® de 1 día para el control de la miopía
(SiMES). IOVS 2008;49(13):4469.Chua S.Y.L., Foster P.J. (2020) The Economic and Societal Impact of Myopia and High Myopia:53-63. In: Ang M., Wong T. (eds) Updates on Myopia. Springer, SingaporeK. Zadnik et al. Factors Associated with Rapid Myopia Progression in School-aged Children. IOVS
More news about: CooperVision, Inc.
Jan 06, 2026, 08:25 ET Behind the Relapse No One Saw Coming: How First Ascent Biomedical Is Changing Cancer Treatment Decisions
Abdella, H., Maher, O. M., Vorontsova, Y., Andrade-Feraud, C. M., Daccache, A., Jacome, A., Reis, V., Holcomb, B., Ghurani, Y., Rimblas, L., Guilarte, T. R., & Hu, N. (2024). Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers. Nature Medicine,
More news about: First Ascent Biomedical
Jan 06, 2026, 08:03 ET Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity in a Phase 2 study
severity. Arch Gynecol Obstet. 2008 Mar;277(3):245-8. DOI: 10.1007/s00404-007-0446-x. Last accessed: January 2026.18 Roy S, Nanovskaya T, Patrikeeva S, et al. M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model. Am J Obstet Gynecol. 2019;220(5):498
More news about: Johnson & Johnson
Jan 06, 2026, 08:01 ET Lupus Research Alliance Launches New Philanthropic Fund to Advance Treatments and Diagnostics
building a research engine that supports every part of the scientific process — from basic and translational research through clinical development," Albert T. Roy, President & CEO of the Lupus Research Alliance, said. "Launching Lupus Ventures is the natural — and critical — next step. It allows us to strategically
More news about: Lupus Research Alliance
Jan 06, 2026, 08:00 ET Sensydia Announces American Medical Association Category III CPT® Code for Noninvasive AI Hemodynamic Assessment
published a new industry-first Category III CPT® code, 1036T, for noninvasive augmentative AI hemodynamic assessment, encompassing Sensydia's
More news about: Sensydia
Jan 06, 2026, 08:00 ET CooperVision to Launch MyDay® MiSight® 1 day Myopia Control Soft Contact Lenses
(SiMES). IOVS 2008;49(13):4469.Chua S.Y.L., Foster P.J. (2020) The Economic and Societal Impact of Myopia and High Myopia:53-63. In: Ang M., Wong T. (eds) Updates on Myopia. Springer, SingaporeK. Zadnik et al. Factors Associated with Rapid Myopia Progression in School-aged Children. IOVS
More news about: CooperVision, Inc.
Jan 06, 2026, 07:30 ET Safehold Closes Ground Lease for Affordable Housing Development in Woodland Hills
Steve WylderHead of Investments T: 310.315.5566E: [email protected]
More news about: Safehold
Jan 06, 2026, 07:30 ET Eminent Intercepts 9.2m @ 3.2 g/t Au and Appoints Dan McCoy as President and CEO
that the true width is at least 60% of the intercept width. This intercept is in a broader envelope that begins and ends in >0.25 g/t and equals = 31.8 m @ 1.0 g/t Au.Geological InterpretationHole HSC005 is the first to penetrate the NW-trending Little
More news about: Eminent Gold Corp.
Jan 06, 2026, 07:19 ET FDA Grants Orphan Drug Designation to Cellenkos' CK0804 Treg Therapy for Treatment of Myelofibrosis
Jan. 6, 2026 /PRNewswire/ -- Cellenkos® Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf, regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation
More news about: Cellenkos, Inc.
Jan 06, 2026, 07:00 ET Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
gene therapy drug candidate which may have the potential for long-term control of Type 1 diabetes (T1D) and Type 2 diabetes (T2D), in a non-human primate (NHP) model of T2D and in a mouse model of T2D.
More news about: Genprex, Inc.
Jan 06, 2026, 07:00 ET AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion
tumors. AbelZeta advances research and development in its own GMP facilities at its centers of excellence, with a pipeline comprised of multiple CAR-T therapies.Forward-Looking StatementsStatements in this communication relating to plans, strategies, specific activities, and other
More news about: AbelZeta Pharma, Inc.
Jan 06, 2026, 07:00 ET BOARDWALKTECH EXPANDS AND EXTENDS CONTRACT WITH GLOBAL SERVICES FIRM SERVICING TOP‑FIVE U.S. BANK
often rely on thousands of Excel‑based workflows that were never designed to meet today's increased regulatory and operational demands," said Andrew T. Duncan, Chief Executive Officer of Boardwalktech. "Velocity allows banks to modernize those workflows quickly and cost‑effectively, without disrupting
More news about: Boardwalktech Software Corp.
Jan 06, 2026, 07:00 ET REDMAGIC Astra 게이밍 태블릿, Snapdragon 8 Elite와 165Hz OLED로 무장한 채 한국 상륙
컴팩트한 디자인과 고급스러운 느낌Snapdragon 8 Elite와 함께 LPDDR5T RAM, UFS 4.1 프로(UFS 4.1 Pro) 스토리지를 탑재한 REDMAGIC Astra는 우수한 프레임 속도와 빠른 앱 구동, 안정적인 멀티태스킹에 최적화되어 있다. 전용 RedCore R3 Pro 게이밍 코프로세서는 렌더링, 발열 관리, 배터리 효율, 시스템
More news about: REDMAGIC
Jan 06, 2026, 06:56 ET Esco Aster firma un contrato de fabricación clínica de exosomas con Shine-On Biomedical
acondicionados por ciclo. Esco Aster también codesarrolla programas de terapia celular autóloga en la ASEAN, incluyendo una plataforma de reactivación de células T dirigida al CPNM con mutación de KRAS no G12C.Esco Aster apoya a los innovadores de Asia-Pacífico mediante la ampliación de la biofabricación,
More news about: Esco Aster
Jan 06, 2026, 06:30 ET GoldMining Reports New Drill Results Highlighting Exploration Potential at São Jorge Project, Pará State, Brazil
12 metres ("m") at 2.38 grams per tonne ("g/t") gold ("Au") from 13 m depth, including 1 m at 22 g/t Au (SJRC-048-25)4 m at 1.11 g/t Au from 46 m depth (SJRC-049-25)1 m at 1.23 g/t Au from 16 m depth (SJRC-047-25)Preliminary
More news about: GoldMining Inc.
Jan 06, 2026, 06:30 ET Thailand recebe o Ano-Novo na 'Times Square da Ásia' de Bangkok, o Central World
continuou sendo o ponto central da celebração, com a centralwOrld apresentando um "Festival Mundial de Música" ininterrupto com os principais artistas de T-Pop da Tailândia. Todas as apresentações foram produzidas exclusivamente para o palco da contagem regressiva do centralwOrld, e o evento também marcou
More news about: CENTRAL PATTANA
Jan 06, 2026, 06:19 ET Timekettle oznamuje průlom v AI tlumočení pro rok 2026: představuje špičkový výběr překladových zařízení a novou generaci zachycení hlasu pomocí kostní vodivosti
podnikové využití,AI překladač T1 : nejrychlejší offline překladač na světě nyní kombinuje technologii Edge AI s funkcí SOTA Engine Selector pro zvýšení přesnosti nad jeho již
More news about: Timekettle
Jan 06, 2026, 05:36 ET Hisense presenta "Innovando para una vida más brillante" en CES 2026
informáticas inteligentes de alta calidad. Según Omdia, Hisense ocupa el primer puesto a nivel mundial en el segmento de televisores de 100 pulgadas o más (2023-T3 2025). Como creador del RGB MiniLED, Hisense continúa liderando la innovación de la próxima generación de RGB MiniLED. Como patrocinador oficial de
More news about: Hisense
Jan 06, 2026, 03:37 ET Timekettle dévoile les avancées de 2026 en matière d'interprétation assistée par l'IA, avec un sélecteur de moteur de traduction de pointe et une capture vocale par conduction osseuse de nouvelle génération
T1 AI Translator : le traducteur hors ligne le plus rapide au monde associe désormais l'intelligence artificielle en périphérie du réseau
More news about: Timekettle
Jan 06, 2026, 03:33 ET Timekettle vyhlasuje prelomové objavy v oblasti interpretácie pomocou AI na rok 2026 - uvádza svoj najmodernejší prekladací nástroj a zachytávanie hlasu kostným snímaním novej generácie
T1 AI Translator: Najrýchlejší offline prekladač na svete teraz kombinuje Edge AI s nástrojom SOTA Engine Selector, aby zvýšil presnosť nad
More news about: Timekettle
Jan 06, 2026, 03:19 ET Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
Orforglipron developed by Eli Lilly and Co | Obesity and T2DMA once-daily, oral small-molecule GLP-1 RA for managing overweight/obesity and T2DM, also under investigation for obstructive sleep apnea and hypertension in individuals with obesity.
More news about: Clarivate Plc
Jan 06, 2026, 03:07 ET Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
Orforglipron developed by Eli Lilly and Co | Obesity and T2DMA once-daily, oral small-molecule GLP-1 RA for managing overweight/obesity and T2DM, also under investigation for obstructive sleep apnea and hypertension in individuals with obesity.
More news about: Clarivate Plc